Approval · Notice of Compliance 4966 · 1995
GEN-CAPTOPRIL: Notice of Compliance 4966
Issued April 18, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4966
- Date
- April 18, 1995
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-CAPTOPRIL | 02163551 | Cancelled Post Market |
| GEN-CAPTOPRIL | 02163578 | Cancelled Post Market |
| GEN-CAPTOPRIL | 02163586 | Cancelled Post Market |
| GEN-CAPTOPRIL | 02163594 | Cancelled Post Market |